CLPT Stock Analysis
CL
Uncovered
Clearpoint Neuro Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 108 full-time employees. The company went IPO on 2019-07-03. The firm develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system is an integrated system comprised of hardware components, disposable components and intuitive, menu-driven software. Its hardware components consist primarily of a head fixation frame, computer workstation, and in-room monitor. Its disposable components for its ClearPoint system consist primarily of its SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Cannula. Its ClearPoint system software guides the physician in surgical planning, device alignment, navigation to the target and procedure monitoring. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance.